Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neutropenia in Breast Cancer”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Large-scale testing (Phase 3)Study completedNCT01516736
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Who this might be right for
Chemotherapy-induced NeutropeniaBreast Cancer
Sandoz 308
Testing effectiveness (Phase 2)Ended earlyNCT02685111
What this trial is testing

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Who this might be right for
Breast CancerNeutropeniaFebrile Neutropenia
Asan Medical Center 22
Early research (Phase 1)Ended earlyNCT05622058
What this trial is testing

ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Who this might be right for
Prevention of Chemotherapy-induced Myelosuppression
Aileron Therapeutics, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT01648322
What this trial is testing

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 232
Testing effectiveness (Phase 2)Study completedNCT03314805
What this trial is testing

PG2 Breast Cancer Evaluation in Adjuvant Medicine Study

Who this might be right for
Cancer-related FatigueNeutropenia, Malignant
PhytoHealth Corporation 67
Not applicableStudy completedNCT02178475
What this trial is testing

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 943
Post-approval studies (Phase 4)UnknownNCT05949333
What this trial is testing

Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy

Who this might be right for
Breast Neoplasms
Eunseong Medical Foundation Good GANG-AN HOSPITAL 100
Not applicableStudy completedNCT05709158
What this trial is testing

Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)

Who this might be right for
Breast Cancer
Pfizer 4,184
Large-scale testing (Phase 3)UnknownNCT02761460
What this trial is testing

The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia

Who this might be right for
Breast Cancer
wang shusen 338
Early research (Phase 1)Study completedNCT02527746
What this trial is testing

Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
NeutropeniaBreast Cancer
EVIVE Biotechnology 18
Testing effectiveness (Phase 2)Looking for participantsNCT07380646
What this trial is testing

The Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Who this might be right for
LeucogenRibociclibNeutropenia (Low White Blood Cell Count)+1 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 94
Large-scale testing (Phase 3)Study completedNCT04554056
What this trial is testing

Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

Who this might be right for
Breast Cancer Female
Mabwell (Shanghai) Bioscience Co., Ltd. 586
Testing effectiveness (Phase 2)Looking for participantsNCT06616987
What this trial is testing

Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Yeon Hee Park 40
Testing effectiveness (Phase 2)Study completedNCT02522234
What this trial is testing

A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Neutropenia
EVIVE Biotechnology 15
Testing effectiveness (Phase 2)Study completedNCT04477616
What this trial is testing

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 160
Testing effectiveness (Phase 2)Study completedNCT04227990
What this trial is testing

Plinabulin iv Solution in Prevention of TAC Induced Neutropenia

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 115
Early research (Phase 1)Study completedNCT03376503
What this trial is testing

Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients

Who this might be right for
Breast Cancer
Nanogen Pharmaceutical Biotechnology Joint Stock Company 24
Not applicableStudy completedNCT03433560
What this trial is testing

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

Who this might be right for
Breast Cancer FemaleBreast Neoplasm Female
Kyowa Kirin Korea Co., Ltd. 1,300
Not applicableStudy completedNCT02428114
What this trial is testing

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 142
Not applicableStudy completedNCT05912933
What this trial is testing

Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Who this might be right for
Breast Cancer
Pfizer 1,342
Next Page